1. TROIKA‐1: A double‐blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU‐Herceptin® and US‐Herceptin® in healthy male subjects. Issue 4 (26th July 2021) Authors: Demarchi, Martin; Coliat, Pierre; Mclendon, Kristi; Chung Shii Hii, Jocelyn; Feyaerts, Peggy; Ang, Felicia; Jaison, Litha; Deforce, Filip; Derde, Marie Paule; Kim, Michael Jinwoo; Park, Lisa Soyeon; Detappe, Alexandre; Pivot, Xavier Journal: Pharmacology research & perspectives Issue: Volume 9:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗